Jazz Pharmaceuticals PLC (JAZZ)
125.42
-2.23
(-1.75%)
USD |
NASDAQ |
Nov 14, 12:53
Jazz Pharmaceuticals Shareholders Equity (Quarterly): 4.171B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 4.171B |
June 30, 2024 | 3.763B |
March 31, 2024 | 3.696B |
December 31, 2023 | 3.737B |
September 30, 2023 | 3.489B |
June 30, 2023 | 3.526B |
March 31, 2023 | 3.335B |
December 31, 2022 | 3.086B |
September 30, 2022 | 2.745B |
June 30, 2022 | 3.201B |
March 31, 2022 | 3.608B |
December 31, 2021 | 3.965B |
September 30, 2021 | 3.938B |
June 30, 2021 | 4.131B |
March 31, 2021 | 3.798B |
December 31, 2020 | 3.660B |
September 30, 2020 | 3.377B |
June 30, 2020 | 3.142B |
March 31, 2020 | 2.808B |
December 31, 2019 | 3.111B |
September 30, 2019 | 3.054B |
June 30, 2019 | 2.983B |
March 31, 2019 | 2.730B |
December 31, 2018 | 2.757B |
September 30, 2018 | 3.027B |
Date | Value |
---|---|
June 30, 2018 | 2.870B |
March 31, 2018 | 2.787B |
December 31, 2017 | 2.713B |
September 30, 2017 | 2.469B |
June 30, 2017 | 2.201B |
March 31, 2017 | 1.984B |
December 31, 2016 | 1.877B |
September 30, 2016 | 1.716B |
June 30, 2016 | 1.692B |
March 31, 2016 | 1.607B |
December 31, 2015 | 1.599B |
September 30, 2015 | 1.563B |
June 30, 2015 | 1.447B |
March 31, 2015 | 1.305B |
December 31, 2014 | 1.371B |
September 30, 2014 | 1.341B |
June 30, 2014 | 1.280B |
March 31, 2014 | 1.249B |
December 31, 2013 | 1.296B |
September 30, 2013 | 1.244B |
June 30, 2013 | 1.175B |
March 31, 2013 | 1.162B |
December 31, 2012 | 1.121B |
September 30, 2012 | 886.09M |
June 30, 2012 | 831.46M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.745B
Minimum
Sep 2022
4.171B
Maximum
Sep 2024
3.514B
Average
3.567B
Median
Shareholders Equity (Quarterly) Benchmarks
Avadel Pharmaceuticals PLC | 70.29M |
Alkermes PLC | 1.292B |
Medtronic PLC | 47.95B |
Perrigo Co PLC | 4.566B |
Iterum Therapeutics PLC | -6.15M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.26B |
Total Liabilities (Quarterly) | 8.085B |
Debt to Equity Ratio | 1.465 |
Current Ratio | 4.263 |
Net Debt Paydown Yield | -1.17% |